Moleculin Reports Cardiac Safety Data for Annamycin
HOUSTON — September 28, 2026 Moleculin Biotech, Inc. announced publication of a peer-reviewed pooled analysis of the cardiac safety...
Cleveland Clinic
Advertisement
Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
Anixa Wins First Korean Patent for Breast Cancer Vaccine
SAN JOSE, Calif., June 29, 2026 Anixa Biosciences, Inc. announced that the Korean Ministry of Intellectual Property (MOIP) has...
Anixa Biosciences Reports Positive Phase 1 Cancer Vaccine Data
June 26, 2026 | San Jose, California, USA Anixa Biosciences, Inc. announced encouraging clinical updates from its two leading...
Anixa Biosciences Completes Final Patient Visit in Breast Cancer Vaccine Trial
SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...
Advertisement
